ProPublica is a nonprofit newsroom that investigates abuses of power. Sign up to receive our biggest stories as soon as they’re published. The calls came over the span of a single month in 2004, ...
Adderall is a central nervous system stimulant prescribed to treat two conditions, attention-deficit/hyperactivity disorder (ADHD) and narcolepsy. If you're ...
The generic product is now available nationwide in strengths of 0.3mg, 0.45mg, 0.625mg, 0.9mg, and 1.25mg. The Food and Drug Administration (FDA) has approved the first generic version of Premarin ® ...
Talent professionals and job seekers alike are grappling with the enormous rise in job applications submitted every day, according to experts. The number of applications submitted on LinkedIn has ...
Before government shutdowns end, political blame games begin. And as politicians from both parties try to blame each other, party operatives and pundits scour the poll data to see who wins the game.
Share on Pinterest The FDA recently approved a generic abortion pill that’s considered as safe and effective as mifepristone. Shuran Huang for The Washington Post via Getty Images The approval, ...
Ed Silverman, a senior writer and Pharmalot columnist at STAT, has been covering the pharmaceutical industry for nearly three decades. He is also the author of the morning Pharmalittle newsletter and ...
Federal regulators have approved a second generic version of the abortion pill mifepristone, a routine step that quickly drew backlash from anti-abortion groups and some Republican lawmakers.
Federal officials have approved another generic version of the abortion pill mifepristone, a regulatory formality that quickly triggered pushback from anti-abortion groups aligned with the Trump ...
As four of the nation’s most accurate pollsters, we recently formed the National Association of Independent Pollsters. The four founding member organizations participated in a joint national survey of ...
US Securities and Exchange Commission Chair Paul Atkins says the new listing standards will reduce barriers to access digital asset products and give investors more choice. ”This approval helps to ...
AbbVie settles with generic Rinvoq hopefuls, shielding the immunology med's US stronghold until 2037
With Rinvoq and its sibling medicine Skyrizi having successfully picked up the sales torch in the wake of Humira’s tumble over the patent cliff, AbbVie is working to cover its legal bases so the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results